UpHealth Group Limited (SGX:GRQ)
Singapore · Delayed Price · Currency is SGD 0.1360
-0.0160 (-10.53%)
At close: Aug 20, 2026
UpHealth Group Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29.96 | - | - | - | 37.94 | 30.94 | |
Revenue Growth | - | - | - | - | 22.60% | -0.17% |
Cost of Revenue | 16.47 | - | - | - | 36.38 | 17.19 |
Gross Profit | 13.49 | - | - | - | 1.56 | 13.75 |
Selling, General & Admin | 16.05 | 6.1 | 6.79 | 1.82 | 3.28 | 3.19 |
Other Operating Expenses | 0.22 | 0.19 | 0.52 | -1.27 | 0.14 | -0.24 |
Operating Expenses | 16.26 | 6.3 | 7.31 | 0.54 | 3.45 | 2.98 |
Operating Income | -2.77 | -6.3 | -7.31 | -0.54 | -1.89 | 10.78 |
Interest Expense | -5.24 | - | - | - | -1.83 | -1.28 |
Interest & Investment Income | 3.24 | 4.18 | 3.38 | 0.03 | 0.32 | 0.17 |
Currency Exchange Gain (Loss) | 0.42 | 0.94 | -0.69 | -0.12 | -0 | 0.07 |
Other Non Operating Income (Expenses) | 0.08 | -0.2 | - | - | 0.57 | 0.25 |
EBT Excluding Unusual Items | -4.28 | -1.37 | -4.62 | -0.64 | -2.84 | 9.99 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.03 | 0.05 |
Asset Writedown | - | - | - | - | 0.87 | -2.05 |
Other Unusual Items | - | - | - | - | 0.16 | 2.63 |
Pretax Income | -4.28 | -1.37 | -4.62 | -0.64 | -1.78 | 10.61 |
Income Tax Expense | 0.2 | - | - | 0.14 | 0.19 | 0.28 |
Earnings From Continuing Operations | -4.48 | -1.37 | -4.62 | -0.78 | -1.97 | 10.33 |
Earnings From Discontinued Operations | - | - | -18.1 | -3.51 | - | - |
Net Income to Company | -4.48 | -1.37 | -22.72 | -4.29 | -1.97 | 10.33 |
Minority Interest in Earnings | 0.15 | - | 0 | 0.01 | -0.02 | -0.01 |
Net Income | -4.33 | -1.37 | -22.72 | -4.27 | -1.98 | 10.32 |
Net Income to Common | -4.33 | -1.37 | -22.72 | -4.27 | -1.98 | 10.32 |
Net Income Growth | - | - | - | - | - | 18.69% |
Shares Outstanding (Basic) | 150 | 150 | 150 | 150 | 150 | 150 |
Shares Outstanding (Diluted) | 150 | 150 | 150 | 150 | 150 | 150 |
Shares Change | - | - | - | - | - | 1.71% |
EPS (Basic) | -0.03 | -0.01 | -0.15 | -0.03 | -0.01 | 0.07 |
EPS (Diluted) | -0.03 | -0.01 | -0.15 | -0.03 | -0.01 | 0.07 |
EPS Growth | - | - | - | - | - | 16.69% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 6.26 | -6.32 | -12.06 | 1.28 | -2.45 | -0.66 |
Free Cash Flow Per Share | 0.04 | -0.04 | -0.08 | 0.01 | -0.02 | -0.00 |
Dividend Per Share | - | - | - | - | - | 0.009 |
Dividend Growth | - | - | - | - | - | -26.72% |
Gross Margin | 45.03% | - | - | - | 4.12% | 44.44% |
Operating Margin | -9.25% | - | - | - | -4.98% | 34.82% |
Profit Margin | -14.46% | - | - | - | -5.23% | 33.35% |
Free Cash Flow Margin | 20.91% | - | - | - | -6.45% | -2.13% |
EBITDA | -0.81 | -5.04 | -6.05 | 1.87 | 0.92 | 12.81 |
EBITDA Margin | -2.69% | - | - | - | 2.43% | 41.39% |
D&A For EBITDA | 1.96 | 1.26 | 1.26 | 2.42 | 2.81 | 2.03 |
EBIT | -2.77 | -6.3 | -7.31 | -0.54 | -1.89 | 10.78 |
EBIT Margin | -9.25% | - | - | - | -4.98% | 34.82% |
Effective Tax Rate | - | - | - | - | - | 2.64% |